3. Mouthwash and Antiseptic Use
Antiseptic mouthwash wipes out helpful nitrate-reducing bacteria along with pathogens, measurably raising blood pressure—so routine daily use is not recommended.
Mouthwash – When It Helps and When It Harms
Not all mouthwashes are equal – and routine antiseptic use may cost more than it cleans [24].
In 1994, a Swedish physiologist named Jon Lundberg and his colleagues at the Karolinska Institute published a finding that initially seemed implausible: a significant proportion of the nitric oxide detected in exhaled human breath was not generated by human cells but by bacteria living in the mouth and nasal sinuses. Nitric oxide – then newly recognised as a critical signalling molecule in vascular regulation, the discovery for which Robert Furchgott, Louis Ignarro, and Ferid Murad had just received the Nobel Prize – was being produced, in part, by oral microbes metabolising dietary nitrate from vegetables. The pathway runs as follows: dietary nitrate from leafy green vegetables is absorbed into circulation and then secreted back into saliva, where specific oral bacteria – including Neisseria and Rothia species – reduce it to nitrite. This nitrite is swallowed, and in the acidic environment of the stomach, converted to nitric oxide, which enters circulation and relaxes vascular smooth muscle, reducing blood pressure. Antiseptic mouthwash, used routinely to reduce oral bacterial load, consistently eliminates a significant proportion of these nitrate-reducing bacteria. Clinical studies have shown that twice-daily antiseptic mouthwash use measurably raises resting blood pressure within days. The bacteria the mouthwash eliminates are not merely passengers in the mouth. They are part of a cardiovascular pathway.
The physiological importance of oral nitrate reduction was not recognized as a health-relevant pathway until dietary nitrate research drew attention to it in the 2010s. A landmark study by Lundberg, Weitzberg, and colleagues at the Karolinska Institute showed that dietary nitrate from vegetables – converted to nitrite by oral bacteria and then to nitric oxide in the acidic environment of the stomach – was a significant source of systemic nitric oxide relevant to blood pressure and vascular function. [252] The bacteria responsible for this conversion are a group of nitrate-reducing Actinobacteria and Proteobacteria that colonize the dorsal surface of the tongue and the periodontal crevice. When Lundberg's group had volunteers use antiseptic mouthwash for seven days, nitrate-to-nitrite conversion was abolished, blood pressure rose measurably, and plasma nitrite fell. [253] A subsequent study by Kapil and colleagues published in Free Radical Biology and Medicine in 2013 demonstrated that a single dose of high-nitrate beetroot juice significantly lowered blood pressure in healthy adults – an effect abolished by concurrent antibacterial mouthwash use. The oral nitrate-reducing microbiota was not merely a curiosity; it was an active mediator of dietary nitrate's cardiovascular benefits. [251] The clinical significance for the gut microbiota is indirect but real: chlorhexidine and broad-spectrum antiseptic mouthwashes eliminate the nitrate-reducing community, reducing systemic nitric oxide availability and potentially contributing to the dysregulation of gut blood flow and mucosal oxygenation that depend on NO signaling. This is an example of how oral microbiome disruption reaches the gut not through microbial seeding but through metabolite signaling.
Mouthwash products span a wide spectrum from alcohol-based cosmetic fresheners to therapeutic antiseptic formulations containing chlorhexidine, essential oil combinations (Listerine-type), cetylpyridinium chloride, hydrogen peroxide, or povidone-iodine. Their effects on the oral microbiome vary markedly depending on active ingredients, concentration, and frequency of use [251].
Chlorhexidine gluconate is the most studied oral antiseptic. At 0.12 to 0.2 percent concentration it is highly effective against a broad spectrum of oral bacteria, reducing plaque scores and gingival inflammation in clinical trials. It is the gold standard for post-surgical oral hygiene and short-term periodontal adjunctive treatment. However, its broad-spectrum bactericidal activity also eliminates commensal oral bacteria, including the nitrate-reducing species responsible for the oral-systemic nitrate pathway.
The disruption of oral nitrate-reducing bacteria by chlorhexidine mouthwash produces measurable acute physiological consequences. Within days of initiating twice-daily chlorhexidine use, salivary nitrite levels fall significantly, blood pressure rises by a measurable margin in healthy volunteers, and exercise-induced vasodilation is impaired. These findings demonstrate that the oral microbiome performs a physiological function – nitrate reduction – that cannot be replaced by the host and is disrupted by broad-spectrum antiseptics.
Essential oil mouthwashes (cetylpyridinium chloride, thymol, eucalyptol, menthol combinations) have antimicrobial activity against plaque-associated bacteria but a somewhat narrower spectrum than chlorhexidine, with less pronounced suppression of beneficial commensal species in some comparative studies. They are commonly used for cosmetic freshening and mild plaque control.
Alcohol-containing mouthwashes contribute to oral mucosal drying through ethanol's dehydrating effect on mucous membranes. Dry oral mucosa has reduced salivary flow and altered mucosal immune function, conditions that reduce the oral microbiome's natural protective capacity. Alcohol-free formulations are preferred for routine and long-term use.
Fluoride mouthwashes support enamel remineralisation and have selective activity against cariogenic acid-producing bacteria with minimal impact on broader oral microbial diversity. They are appropriate for daily use in high caries-risk individuals and are microbiota-neutral at standard concentrations.
Probiotic mouthwashes – containing Streptococcus salivarius K12 or other oral probiotic strains – represent an emerging category that attempts to replace pathobiont-dominated oral communities with commensal-dominant ones. Early clinical data are promising for halitosis reduction and modest shifts in oral microbiome composition, though the field is young.
Mouthwash Use in Clinical Practice
Routine daily antiseptic mouthwash use is not recommended as part of standard oral microbiome-supportive care. The systemic physiological consequences of nitrate-reducing bacterial suppression, combined with broad-spectrum disruption of oral microbial diversity, outweigh the cosmetic and mild antimicrobial benefits for most patients maintaining good mechanical oral hygiene.
Therapeutic antiseptic mouthwash (chlorhexidine) is indicated for specific clinical situations: post-surgical healing periods (implant placement, tooth extraction, periodontal surgery), active periodontal treatment adjunctive therapy, and patients temporarily unable to perform mechanical oral hygiene due to surgery or physical limitation. Duration is limited to the therapeutic window – typically one to four weeks – not extended indefinitely.
Patients prescribed chlorhexidine mouthwash are counselled about the temporary nature of use, the rationale for limitation, and the importance of resuming full mechanical oral hygiene after the course to allow oral microbiome recovery.
Fluoride mouthwash is appropriate for daily use in high caries-risk patients as an adjunct to twice-daily brushing. It does not require usage restriction from a microbiome perspective at standard concentrations.
Patients who use antiseptic mouthwash for breath freshening are guided toward addressing the underlying cause of halitosis (tongue biofilm, interdental plaque, periodontal disease, dry mouth) through mechanical means rather than masking with antiseptics.
Nitrate-rich dietary intake is recommended alongside mouthwash guidance for patients dependent on the oral-gut nitrate pathway for cardiovascular or metabolic support. Disruption of oral nitrate-reducing bacteria by antiseptic mouthwash is especially clinically relevant in patients with hypertension, cardiovascular disease, or exercise intolerance.
Oil pulling – the practice of swishing oil (typically sesame or coconut oil) in the mouth for 10 to 20 minutes – has some traditional and limited clinical evidence for reducing oral pathobiont load with lower collateral damage to commensal bacteria than broad-spectrum antiseptics. It is not a replacement for mechanical oral hygiene but may be offered as a complementary oral care practice for interested patients.
Microbiota Effects
- Chlorhexidine and broad-spectrum antiseptic mouthwashes reduce total oral microbial diversity, eliminating both pathobionts and commensal species including the nitrate-reducing bacteria essential for the oral-systemic nitrate pathway [251].
- Suppression of oral nitrate-reducing bacteria (Neisseria, Rothia, Haemophilus species) by antiseptic mouthwash reduces salivary nitrite production, decreasing downstream nitric oxide availability with measurable effects on blood pressure and vascular function [24].
- Oral microbial diversity typically recovers within days to weeks after cessation of antiseptic mouthwash use, though repeated extended courses may produce more persistent dysbiotic patterns.
- Alcohol-containing mouthwash dries oral mucosa and reduces salivary flow, impeding the natural salivary microbiome maintenance mechanisms including pH buffering and antimicrobial protein delivery.
- Essential oil mouthwashes show less pronounced suppression of beneficial oral commensal species compared to chlorhexidine in some comparative studies, though they are not microbiome-neutral and are still not recommended for routine long-term daily use.
- Probiotic mouthwashes (S. salivarius K12) show early evidence for shifting oral microbial composition toward more commensal-dominant profiles and reducing halitosis-associated anaerobic bacterial load on the tongue.
Patient Guidance
- Do not use antiseptic mouthwash (chlorhexidine, essential oil formulations) routinely every day as a habit.
- Reserve chlorhexidine mouthwash for clinical indications: post-surgical recovery, active periodontal treatment – limit to the prescribed course duration.
- Use fluoride mouthwash daily if you have high caries risk; it is microbiome-safe at standard concentrations.
- If you use mouthwash for breath freshening, address the underlying cause (tongue cleaning, interdental hygiene, dry mouth) rather than masking with antiseptics.
- Choose alcohol-free formulations for any mouthwash you use regularly.
- Eat nitrate-rich vegetables daily to support the oral nitrate-reducing bacteria that produce nitric oxide.
- Discuss oil pulling with your clinician if interested in a lower-impact complementary oral hygiene practice.
- After a course of therapeutic antiseptic mouthwash, resume full mechanical oral hygiene to support oral microbiome recovery.
- If you have hypertension or cardiovascular conditions, discuss antiseptic mouthwash use with both your dental and medical clinicians.
References
[24] Sonnenburg JL, Bäckhed F. Diet–microbiota interactions as moderators of human metabolism. Nature. 2016. Link
Review of mechanisms linking the gut microbiota to obesity and type 2 diabetes drawing on translational animal models and human studies. The microbiota emerges as a mediator of dietary impact on host metabolic status, with growing efforts to establish causal relationships in people and develop therapeutic interventions including personalised nutrition.
[251] Dewhirst FE, Chen T, Izard J et al. The human oral microbiome. J Bacteriol. 2010. Link
This study established the Human Oral Microbiome Database (HOMD, www.homd.org), a curated phylogeny-based 16S rRNA database of the oral microbiota. The HOMD catalogues 619 oral taxa in 13 phyla including Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, Proteobacteria, Spirochaetes, SR1, Synergistetes, Tenericutes and TM7. The resource enables systematic taxonomic anchoring of previously unnamed taxa referenced only by clone or GenBank numbers, supporting reproducible oral microbiome research.
[252] Lundberg JO, Weitzberg E, Gladwin MT. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008. Link
This review highlights the nitrate-nitrite-nitric oxide (NO) pathway as a major alternative source of NO complementary to the L-arginine-NO synthase route, particularly under hypoxia. Inorganic nitrate and nitrite, previously considered inert end products, are recycled in vivo to NO, with biological functions in vasodilation, mitochondrial signalling and cytoprotection. The therapeutic potential of nitrate and nitrite is discussed for myocardial infarction, stroke, systemic and pulmonary hypertension, and gastric ulceration. The findings reframe dietary nitrate as a cardioprotective and metabolic regulator.
[253] Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2013. Link
This randomized crossover study in 19 healthy volunteers tested whether suppressing oral nitrate-reducing bacteria with chlorhexidine antiseptic mouthwash affects systemic nitrite levels and blood pressure. Blood pressure (clinic, home, 24-hour ambulatory) was measured during a 7-day control period and a 7-day chlorhexidine treatment period. Mouthwash use suppressed oral nitrate-reducing flora, reduced systemic nitrite and significantly increased blood pressure. The findings demonstrate that oral microbiota actively contribute to systemic blood pressure regulation via the enterosalivary nitrate-nitrite-NO pathway.